The presence of AR is closely linked to the oncogenic process; increasingly higher levels of AR expression correlate with worse prognosis in several cancers, such as ovarian, glioma, head and neck, breast, and lung cancers [22–24]. This evidence concerns the gene AR and lung cancer.